Oxalic Acid

Oxalic Acid

SCHEMBL6299258

Cc1c(F)cc(N2CCNCC2)c2occc12.O=C(O)C(=O)O

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.41
KDM4E B2RXH2 1/20 0.38
BRD4 O60885 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
CYP2J2 P51589 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ADRB2 P07550 1/20 0.37
ADRA2A P08913 1/20 0.37
HTR2C P28335 1/20 0.37
AXL P30530 1/20 0.37
HRH1 P35367 1/20 0.37
HTR2B P41595 1/20 0.37
MKNK1 Q9BUB5 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6299549 0.80 KDM4E (0.38) HTR6KDM4EALDH1A1LMNAHPGD
Fumaric Acid SCHEMBL6299546 0.80 KDM4E (0.38) HTR6KDM4EALDH1A1LMNAHPGD
Oxalic Acid SCHEMBL6298316 0.79 CCR4 (0.38) HTR6
Oxalic Acid SCHEMBL6304523 0.79 HTR6 (0.36) HTR6KDM4EBRD4ALDH1A1LMNA
Hydrochloric Acid SCHEMBL6300092 0.76 ADRB1 (0.40) ALDH1A1ADRB2HTR2C
Oxalic Acid SCHEMBL6298378 0.75 HTR6 (0.36) HTR6KDM4EALDH1A1HTR2C
Oxalic Acid SCHEMBL6305081 0.74 KDM4E (0.43) HTR6KDM4EHTR2C
Fumaric Acid SCHEMBL6300318 0.74 HRH4 (0.38) HTR6KDM4EALDH1A1LMNANPSR1
Fumaric Acid SCHEMBL6300321 0.74 HRH4 (0.38) HTR6KDM4EALDH1A1LMNANPSR1
Oxalic Acid SCHEMBL6300139 0.73 ALDH1A1 (0.45) HTR6ALDH1A1LMNAHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6967201-B1 for increasing activation of the 5-HT2C receptor in mammals; treatment of depression, obesity, bulimia, premenstrual syndrome, alcoholism, tobacco abuse, panic disorder ELI LILLY AND COMPANY (US) 2005-11-22 US disclosed
EP-1204654-B1 BENZOFURYLPIPERAZINES: 5-HT2C SEROTONIN RECEPTOR AGONISTS LILLY CO ELI (US) 2003-07-23 EP disclosed
EP-1204654-A1 BENZOFURYLPIPERAZINES AND BENZOFURYLHOMOPIPERAZINES: SEROTONIN AGONISTS ELI LILLY AND COMPANY (US) 2002-05-15 EP disclosed
WO-2001009111-A1 BENZOFURYLPIPERAZINES AND BENZOFURYLHOMOPIPERAZINES: SEROTONIN AGONISTS ELI LILLY AND COMPANY (US) 2001-02-08 WO disclosed